SEVEN YEAR GRAFT AND PATIENT SURVIVAL FROM THE NULOJIX PIVOTAL TRIALS
Symposium sponsored by Bristol-Myers Squibb
Tuesday 15 September 2015, 13:00 – 14:00
Gold Hall – The Square Meeting Centre - Brussels, Belgium
PLEASE CLICK HERE TO DOWNLOAD THE FULL PROGRAMME
Co-Chairs: Dr Klemens Budde (Berlin, Germany)
Dr Christophe Legendre (Paris, France)
- BENEFIT Study 7 Year Results
Dr Flavio Vincenti (San Francisco, USA)
- BENEFIT-EXT Study 7 Year Results
Dr Antoine Durrbach (Villejuif, France)
Information
Contact
ESOT Office Riviera dei Mugnai, 8/24 35137 Padova Italy |
esot2015@esot.org T: +39 049 859 7652 F: +39 049 210 6306 |